Regulation of the HIF switch in human endothelial and cancer cells
European Journal of Cell Biology,
Journal Year:
2024,
Volume and Issue:
103(2), P. 151386 - 151386
Published: Jan. 21, 2024
Hypoxia-inducible
factors
(HIFs)
are
transcription
that
reprogram
the
transcriptome
for
cells
to
survive
hypoxic
insults
and
oxidative
stress.
They
important
during
embryonic
development
utilize
glycolysis
when
oxygen
levels
extremely
low.
This
metabolic
change
facilitates
normal
cell
survival
as
well
cancer
survival.
The
key
feature
in
is
transition
between
acute
hypoxia
chronic
hypoxia,
this
regulated
by
HIF-1
expression
HIF-2/HIF-3
expression.
observed
many
human
cancers
endothelial
referred
HIF
Switch.
Here
we
discuss
mechanisms
involved
Switch
which
include
mRNA
protein
of
alpha
chains
HIFs.
A
major
continuing
effort
field
directed
towards
determining
differences
tumor
utilization
pathway,
how
could
lead
potential
therapeutic
approaches.
Language: Английский
The functional regulation between extracellular vesicles and the DNA damage responses
Jin‐Yi Han,
No information about this author
Kexin Xu,
No information about this author
Ting Xu
No information about this author
et al.
Mutation Research/Reviews in Mutation Research,
Journal Year:
2025,
Volume and Issue:
795, P. 108532 - 108532
Published: Jan. 1, 2025
Language: Английский
Hypoxia and intrinsic radiosensitivity: Exploring mechanisms in radiation resistance of cancers and biomarkers for enhanced treatment strategies
Elham Khakshour,
No information about this author
Mohammad Amin Shahram,
No information about this author
Reza Chaman
No information about this author
et al.
Journal of Radiation Research and Applied Sciences,
Journal Year:
2025,
Volume and Issue:
18(2), P. 101450 - 101450
Published: April 3, 2025
Language: Английский
Unravelling the role of extracellular vesicles in cervical cancer: Mechanisms of progression, resistance, and emerging therapeutic strategies
Gene,
Journal Year:
2025,
Volume and Issue:
unknown, P. 149467 - 149467
Published: April 1, 2025
Language: Английский
5-aminolevulinic acid photodynamic therapy inhibits the viability, invasion, and migration of cervical cancer SiHa cells by regulating the miR-152-3p/JAK1/STAT1 axis
Photodiagnosis and Photodynamic Therapy,
Journal Year:
2024,
Volume and Issue:
49, P. 104283 - 104283
Published: July 18, 2024
Cervical
cancer
ranks
the
fourth
most
prevalent
type
of
worldwide,
characterized
by
a
notably
low
survival
rate,
particularly
in
its
metastatic
stage.
Despite
5-aminolevulinic
acid
photodynamic
therapy
(ALA-PDT)
demonstrating
potential
anti-tumor
effects
against
cervical
cancer,
intricate
mechanisms
underlying
efficacy
necessitate
further
investigation.
Here,
study
aims
to
elucidate
impact
ALA-PDT
on
cell
viability,
invasion
and
migration,
alongside
delineating
molecular
mechanisms.
SiHa
cells
were
subjected
ALA
red
light
irradiation,
we
then
measured
ALA-PDT's
functions
using
various
assays.
The
interaction
between
miR-152-3p
JAK1
was
explored
through
bioinformatics
analyses
validated
dual-luciferase
reporter
Post-transfection
with
vectors,
cellular
re-evaluated.
tumor
suppression
investigated
transplantation
experiment
vivo.
markedly
suppressed
impacting
critical
markers
proliferation,
apoptosis,
epithelial-mesenchymal
transition(EMT).
And
these
echoed
inhibition
miR-152-3p.
identified
as
direct
target
miR-152-3p,
found
regulate
expression
levels
consequently
influencing
JAK1/STAT1
signaling
pathway.
Augmentation
pathway
mitigated
anti-cancer
ALA-PDT,
whereas
overexpression
diminished
effects.
In
vivo
demonstrated
that
growth
modulated
miR-152-3p/JAK1/STAT1
expression.
inhibits
invasion,
migration
modulating
axis,
offering
promising
therapeutic
avenue
for
combating
invasive
cancer.
Language: Английский
The role of extracellular vesicles in the pathogenesis of gynecological cancer
Madhura Chatterjee,
No information about this author
Saurabh Gupta,
No information about this author
Tanmoy Mukherjee
No information about this author
et al.
Frontiers in Oncology,
Journal Year:
2024,
Volume and Issue:
14
Published: Sept. 26, 2024
Gynecological
cancer,
the
most
common
form
of
cancers
in
women
worldwide,
initiates
reproductive
organs
females.
More
often,
treatment
measures,
i.e.
surgery,
radiation,
and
medical
oncology
are
found
to
be
unsuccessful
gynecological
tumors.
Emerging
evidence
indicates
that
extracellular
vesicles
(EVs)
play
a
significant
role
pathogenesis
by
distinct
mechanisms.
The
present
review
highlights
how
EVs
contribute
progression
different
types
such
as
cervical
endometrial
ovarian
vaginal
uterine
sarcoma,
gestational
trophoblastic
disease
(GTD),
vulvar
cancer.
primary
focus
is
understand
EVs’
cargo
alters
phenotypic
response
recipient
cells,
thereby
contributing
disease,
thus
can
considered
prognostic
diagnostic
biomarker.
A
brief
discussion
on
diagnosis
prognosis
cancer
also
highlighted.
Targeting
biogenesis
EVs,
their
inside
cargo,
uptake
cells
could
potential
therapeutic
approach
beside
conventional
means.
Language: Английский
The signature of extracellular vesicles in hypoxic breast cancer and their therapeutic engineering
Beiqing Zhu,
No information about this author
Kehao Xiang,
No information about this author
Tanghua Li
No information about this author
et al.
Cell Communication and Signaling,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Oct. 21, 2024
Abstract
Breast
cancer
(BC)
currently
ranks
second
in
the
global
incidence
rate.
Hypoxia
is
a
common
phenomenon
BC.
Under
hypoxic
conditions,
cells
tumor
microenvironment
(TME)
secrete
numerous
extracellular
vesicles
(EVs)
to
achieve
intercellular
communication
and
alter
metabolism
of
primary
metastatic
tumors
that
shape
TME.
In
addition,
emerging
studies
have
indicated
hypoxia
can
promote
resistance
treatment.
Engineered
EVs
are
expected
become
carriers
for
treatment
due
their
high
biocompatibility,
low
immunogenicity,
drug
delivery
efficiency,
ease
modification.
this
review,
we
summarize
mechanisms
TME
distant
metastasis
BC
under
conditions.
Additionally,
highlight
potential
applications
engineered
mitigating
malignant
phenotypes
hypoxia.
Language: Английский
5-Aminolevulinic Acid Photodynamic Therapy Inhibits the Viability, Invasion, and Migration of Cervical Cancer Siha Cells by Regulating the Mir-152-3p/Jak1/Stat1 Axis
Published: Jan. 1, 2024
Download
This
Paper
Open
PDF
in
Browser
Add
to
My
Library
Share:
Permalink
Using
these
links
will
ensure
access
this
page
indefinitely
Copy
URL
DOI
Language: Английский
RNA biomarkers in cancer therapeutics: The promise of personalized oncology
Advances in clinical chemistry,
Journal Year:
2024,
Volume and Issue:
unknown, P. 179 - 219
Published: Jan. 1, 2024
Language: Английский
The role of miR-152 in urological tumors: potential biomarkers and therapeutic targets
Xin Li,
No information about this author
Biao Qian,
No information about this author
Xu Chen
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 13, 2024
Urological
malignant
tumors
pose
a
significant
threat
to
human
health,
with
high
incidence
rate
each
year.
Prostate
cancer,
bladder
and
renal
cell
carcinoma
are
among
the
most
prevalent
extensively
researched
urological
malignancies.
Despite
advancements
in
research,
prognosis
for
these
remains
unfavorable
due
late
detection,
postoperative
recurrence,
treatment
resistance.
A
thorough
investigation
into
their
pathogenesis
is
crucial
early
diagnosis
treatment.
Recent
studies
have
highlighted
close
association
between
microRNAs
(miRNAs)
cancer
progression.
miRNAs
small
non-coding
RNAs
composed
of
19-23
nucleotides
that
regulate
gene
expression
by
binding
3’
untranslated
region
(3’UTR)
target
mRNAs,
impacting
key
cellular
processes
such
as
proliferation,
differentiation,
apoptosis,
migration.
Dysregulation
can
disrupt
oncogenes
tumor
suppressor
genes,
contributing
development.
Among
various
studied,
miR-152
has
garnered
attention
its
role
Several
indicated
dysregulation
cancers,
warranting
comprehensive
review
evidence.
This
focuses
on
function
prostate
carcinoma,
elucidating
mechanisms
progression
exploring
potential
therapeutic
biomarker
Language: Английский